Viatris, Inc. (VTRS)
16.56
+0.18
(+1.07%)
USD |
NASDAQ |
Sep 11, 13:46
Viatris Gross Profit (TTM) : 5.838B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.838B |
| March 31, 2026 | 5.667B |
| December 31, 2025 | 5.501B |
| September 30, 2025 | 5.322B |
| June 30, 2025 | 5.506B |
| March 31, 2025 | 5.546B |
| December 31, 2024 | 5.852B |
| September 30, 2024 | 6.148B |
| June 30, 2024 | 6.264B |
| March 31, 2024 | 6.509B |
| December 31, 2023 | 6.565B |
| September 30, 2023 | 6.376B |
| June 30, 2023 | 6.457B |
| March 31, 2023 | 6.463B |
| December 31, 2022 | 6.688B |
| September 30, 2022 | 6.943B |
| June 30, 2022 | 6.969B |
| March 31, 2022 | 6.774B |
| December 31, 2021 | 6.350B |
| September 30, 2021 | 5.707B |
| June 30, 2021 | 5.081B |
| March 31, 2021 | 4.608B |
| December 31, 2020 | 4.140B |
| September 30, 2020 | 4.335B |
| June 30, 2020 | 4.252B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.201B |
| December 31, 2019 | 4.111B |
| September 30, 2019 | 3.919B |
| June 30, 2019 | 3.926B |
| March 31, 2019 | 3.951B |
| December 31, 2018 | 4.12B |
| September 30, 2018 | 4.382B |
| June 30, 2018 | 4.488B |
| March 31, 2018 | 4.728B |
| December 31, 2017 | 4.824B |
| September 30, 2017 | 4.871B |
| June 30, 2017 | 4.968B |
| March 31, 2017 | 4.909B |
| December 31, 2016 | 4.775B |
| September 30, 2016 | 4.554B |
| June 30, 2016 | 4.613B |
| March 31, 2016 | 4.480B |
| December 31, 2015 | 4.391B |
| September 30, 2015 | 4.347B |
| June 30, 2015 | 4.046B |
| March 31, 2015 | 3.812B |
| December 31, 2014 | 3.894B |
| September 30, 2014 | 3.661B |
| June 30, 2014 | 3.450B |
| March 31, 2014 | 3.393B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Pfizer Inc. | 41.30B |
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| Bristol Myers Squibb Co. | 32.78B |
| Johnson & Johnson | 66.63B |